STOCK TITAN

IVVD insider sale: 39,600 shares from RSU vesting to be sold Aug 18, 2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Invivyd, Inc. (IVVD) filed a Form 144 reporting a proposed sale of 39,600 shares of common stock on 08/18/2025 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $28,001.16. The shares were acquired on 08/15/2025 upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan; 99,000 shares were acquired upon vesting and payment was by equity compensation on 08/15/2025. The filing shows 120,142,811 shares outstanding and indicates no reported sales by the seller in the past three months.

Positive

  • Full disclosure of planned sale: Form 144 provides broker, share count, market value, and planned sale date.
  • Securities originated from RSU vesting: The shares were acquired on 08/15/2025 under the 2021 Equity Incentive Plan, indicating compensation-based acquisition rather than a new purchase.
  • No sales in prior three months: The filer reported "Nothing to Report" for securities sold during the past three months, suggesting this is not part of recent frequent selling.

Negative

  • None.

Insights

TL;DR: Routine insider sale disclosure; shares originated from RSU vesting and will be sold through an institutional broker.

The Form 144 documents a planned sale of 39,600 common shares with an aggregate market value of $28,001.16, executed via Morgan Stanley Smith Barney LLC. The underlying position arose from restricted stock units vesting on 08/15/2025 under the companys 2021 Equity Incentive Plan. No sales by the reporting person were reported in the prior three months, suggesting this is a discrete disposition tied to recent vesting rather than ongoing liquidation.

TL;DR: Disclosure aligns with Rule 144 requirements; transaction appears procedural and compliant.

The filer has provided the necessary Rule 144 information: acquisition date, nature of acquisition (equity compensation), broker details, and planned sale date. The representation regarding lack of material nonpublic information is included on the form. This filing fulfills routine insider reporting and transfer mechanics following RSU vesting.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Invivyd's (IVVD) Form 144 report?

The Form 144 reports a proposed sale of 39,600 common shares with an aggregate market value of $28,001.16, to be sold on 08/18/2025 via Morgan Stanley Smith Barney LLC.

How were the shares being sold by the IVVD filer acquired?

The shares were acquired on 08/15/2025 upon vesting of restricted stock units granted under Invivyd's 2021 Equity Incentive Plan.

How many Invivyd shares are outstanding according to the filing?

The filing reports 120,142,811 shares outstanding.

Did the filer report any securities sold in the past three months?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months.

Which broker will handle the sale reported in IVVD's Form 144?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

688.05M
223.47M
19.2%
60.75%
2.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW HAVEN